Quinine Sulfate Prior Authorization Criteria - Medicare Part D
Medicare Utilization Management Policy
Version Date: January 1, 2025
Prior Authorization Criteria for Approval
Quinine sulfate will be approved when BOTH of the following are met:
-
The patient has ONE of the following diagnoses:
- Uncomplicated malaria
OR - Babesiosis
OR - An indication that is supported in CMS approved compendia for the requested medication
AND
- Uncomplicated malaria
-
The patient does NOT have any FDA labeled contraindications to the requested medication
Length of Approval:
Malaria: 7 days
Babesiosis: 10 days
Other diagnoses: 12 months